id	sid	tid	token	lemma	pos
cord-285833-7exenodj	1	1	key	key	JJ
cord-285833-7exenodj	1	2	:	:	:
cord-285833-7exenodj	1	3	cord-285833	cord-285833	NNP
cord-285833-7exenodj	1	4	-	-	HYPH
cord-285833-7exenodj	1	5	7exenodj	7exenodj	CD
cord-285833-7exenodj	1	6	authors	author	NNS
cord-285833-7exenodj	1	7	:	:	:
cord-285833-7exenodj	1	8	Alkan	Alkan	NNP
cord-285833-7exenodj	1	9	,	,	,
cord-285833-7exenodj	1	10	Ali	Ali	NNP
cord-285833-7exenodj	1	11	;	;	:
cord-285833-7exenodj	1	12	Uncu	Uncu	NNP
cord-285833-7exenodj	1	13	,	,	,
cord-285833-7exenodj	1	14	Asaf	Asaf	NNP
cord-285833-7exenodj	1	15	;	;	:
cord-285833-7exenodj	1	16	Taşkıran	Taşkıran	NNP
cord-285833-7exenodj	1	17	,	,	,
cord-285833-7exenodj	1	18	Irmak	Irmak	NNP
cord-285833-7exenodj	1	19	;	;	:
cord-285833-7exenodj	1	20	Tanrıverdi	Tanrıverdi	NNP
cord-285833-7exenodj	1	21	,	,	,
cord-285833-7exenodj	1	22	Özgür	Özgür	NNP
cord-285833-7exenodj	2	1	title	title	NN
cord-285833-7exenodj	2	2	:	:	:
cord-285833-7exenodj	2	3	Double	double	RB
cord-285833-7exenodj	2	4	-	-	HYPH
cord-285833-7exenodj	2	5	edged	edged	JJ
cord-285833-7exenodj	2	6	sword	sword	NN
cord-285833-7exenodj	2	7	:	:	:
cord-285833-7exenodj	3	1	Granulocyte	Granulocyte	NNP
cord-285833-7exenodj	3	2	colony	colony	NN
cord-285833-7exenodj	3	3	stimulating	stimulate	VBG
cord-285833-7exenodj	3	4	factors	factor	NNS
cord-285833-7exenodj	3	5	in	in	IN
cord-285833-7exenodj	3	6	cancer	cancer	NN
cord-285833-7exenodj	3	7	patients	patient	NNS
cord-285833-7exenodj	3	8	during	during	IN
cord-285833-7exenodj	3	9	the	the	DT
cord-285833-7exenodj	3	10	COVID-19	covid-19	JJ
cord-285833-7exenodj	3	11	era	era	NN
cord-285833-7exenodj	3	12	date	date	NN
cord-285833-7exenodj	3	13	:	:	:
cord-285833-7exenodj	3	14	2020	2020	CD
cord-285833-7exenodj	3	15	-	-	HYPH
cord-285833-7exenodj	3	16	07	07	CD
cord-285833-7exenodj	3	17	-	-	HYPH
cord-285833-7exenodj	3	18	02	02	CD
cord-285833-7exenodj	3	19	journal	journal	NN
cord-285833-7exenodj	3	20	:	:	:
cord-285833-7exenodj	4	1	Clinics	clinic	NNS
cord-285833-7exenodj	4	2	(	(	-LRB-
cord-285833-7exenodj	4	3	Sao	Sao	NNP
cord-285833-7exenodj	4	4	Paulo	Paulo	NNP
cord-285833-7exenodj	4	5	)	)	-RRB-
cord-285833-7exenodj	5	1	DOI	DOI	NNP
cord-285833-7exenodj	5	2	:	:	:
cord-285833-7exenodj	6	1	10.6061	10.6061	CD
cord-285833-7exenodj	6	2	/	/	SYM
cord-285833-7exenodj	6	3	clinics/2020	clinics/2020	NNS
cord-285833-7exenodj	6	4	/	/	SYM
cord-285833-7exenodj	6	5	e2033	e2033	NNP
cord-285833-7exenodj	6	6	sha	sha	NNP
cord-285833-7exenodj	6	7	:	:	:
cord-285833-7exenodj	7	1	91f52736e05e1685a5065d5a12d7338829dcbcfa	91f52736e05e1685a5065d5a12d7338829dcbcfa	LS
cord-285833-7exenodj	7	2	doc_id	doc_id	CD
cord-285833-7exenodj	7	3	:	:	:
cord-285833-7exenodj	7	4	285833	285833	CD
cord-285833-7exenodj	7	5	cord_uid	cord_uid	NNS
cord-285833-7exenodj	7	6	:	:	:
cord-285833-7exenodj	8	1	7exenodj	7exenodj	DT
cord-285833-7exenodj	8	2	nan	nan	NNP
cord-285833-7exenodj	9	1	To	to	IN
cord-285833-7exenodj	9	2	the	the	DT
cord-285833-7exenodj	9	3	Editor	Editor	NNP
cord-285833-7exenodj	9	4	,	,	,
cord-285833-7exenodj	9	5	The	the	DT
cord-285833-7exenodj	9	6	whole	whole	JJ
cord-285833-7exenodj	9	7	world	world	NN
cord-285833-7exenodj	9	8	is	be	VBZ
cord-285833-7exenodj	9	9	struggling	struggle	VBG
cord-285833-7exenodj	9	10	because	because	IN
cord-285833-7exenodj	9	11	of	of	IN
cord-285833-7exenodj	9	12	coronavirus	coronavirus	NN
cord-285833-7exenodj	9	13	disease	disease	NN
cord-285833-7exenodj	9	14	,	,	,
cord-285833-7exenodj	9	15	and	and	CC
cord-285833-7exenodj	9	16	it	-PRON-	PRP
cord-285833-7exenodj	9	17	has	have	VBZ
cord-285833-7exenodj	9	18	already	already	RB
cord-285833-7exenodj	9	19	triggered	trigger	VBN
cord-285833-7exenodj	9	20	a	a	DT
cord-285833-7exenodj	9	21	series	series	NN
cord-285833-7exenodj	9	22	of	of	IN
cord-285833-7exenodj	9	23	crises	crisis	NNS
cord-285833-7exenodj	9	24	.	.	.
cord-285833-7exenodj	10	1	Patients	patient	NNS
cord-285833-7exenodj	10	2	with	with	IN
cord-285833-7exenodj	10	3	comorbidities	comorbiditie	NNS
cord-285833-7exenodj	10	4	are	be	VBP
cord-285833-7exenodj	10	5	highly	highly	RB
cord-285833-7exenodj	10	6	susceptible	susceptible	JJ
cord-285833-7exenodj	10	7	to	to	IN
cord-285833-7exenodj	10	8	infection	infection	NN
cord-285833-7exenodj	10	9	and	and	CC
cord-285833-7exenodj	10	10	thus	thus	RB
cord-285833-7exenodj	10	11	have	have	VB
cord-285833-7exenodj	10	12	a	a	DT
cord-285833-7exenodj	10	13	poor	poor	JJ
cord-285833-7exenodj	10	14	prognosis	prognosis	NN
cord-285833-7exenodj	10	15	.	.	.
cord-285833-7exenodj	11	1	Cancer	cancer	NN
cord-285833-7exenodj	11	2	patients	patient	NNS
cord-285833-7exenodj	11	3	have	have	VBP
cord-285833-7exenodj	11	4	been	be	VBN
cord-285833-7exenodj	11	5	heavily	heavily	RB
cord-285833-7exenodj	11	6	impacted	impact	VBN
cord-285833-7exenodj	11	7	by	by	IN
cord-285833-7exenodj	11	8	the	the	DT
cord-285833-7exenodj	11	9	onset	onset	NN
cord-285833-7exenodj	11	10	of	of	IN
cord-285833-7exenodj	11	11	this	this	DT
cord-285833-7exenodj	11	12	pandemic	pandemic	NN
cord-285833-7exenodj	11	13	.	.	.
cord-285833-7exenodj	12	1	A	a	DT
cord-285833-7exenodj	12	2	few	few	JJ
cord-285833-7exenodj	12	3	recent	recent	JJ
cord-285833-7exenodj	12	4	studies	study	NNS
cord-285833-7exenodj	12	5	on	on	IN
cord-285833-7exenodj	12	6	cancer	cancer	NN
cord-285833-7exenodj	12	7	patients	patient	NNS
cord-285833-7exenodj	12	8	have	have	VBP
cord-285833-7exenodj	12	9	shown	show	VBN
cord-285833-7exenodj	12	10	that	that	IN
cord-285833-7exenodj	12	11	they	-PRON-	PRP
cord-285833-7exenodj	12	12	are	be	VBP
cord-285833-7exenodj	12	13	at	at	IN
cord-285833-7exenodj	12	14	an	an	DT
cord-285833-7exenodj	12	15	increased	increase	VBN
cord-285833-7exenodj	12	16	risk	risk	NN
cord-285833-7exenodj	12	17	for	for	IN
cord-285833-7exenodj	12	18	severe	severe	JJ
cord-285833-7exenodj	12	19	acute	acute	JJ
cord-285833-7exenodj	12	20	respiratory	respiratory	JJ
cord-285833-7exenodj	12	21	syndrome	syndrome	NN
cord-285833-7exenodj	12	22	-	-	HYPH
cord-285833-7exenodj	12	23	coronavirus-2	coronavirus-2	NNP
cord-285833-7exenodj	13	1	(	(	-LRB-
cord-285833-7exenodj	13	2	SARS	SARS	NNP
cord-285833-7exenodj	13	3	-	-	HYPH
cord-285833-7exenodj	13	4	CoV-2	CoV-2	NNP
cord-285833-7exenodj	13	5	)	)	-RRB-
cord-285833-7exenodj	13	6	infection	infection	NN
cord-285833-7exenodj	13	7	.	.	.
cord-285833-7exenodj	14	1	Furthermore	furthermore	RB
cord-285833-7exenodj	14	2	,	,	,
cord-285833-7exenodj	14	3	infected	infected	JJ
cord-285833-7exenodj	14	4	patients	patient	NNS
cord-285833-7exenodj	14	5	were	be	VBD
cord-285833-7exenodj	14	6	found	find	VBN
cord-285833-7exenodj	14	7	to	to	TO
cord-285833-7exenodj	14	8	have	have	VB
cord-285833-7exenodj	14	9	an	an	DT
cord-285833-7exenodj	14	10	increased	increase	VBN
cord-285833-7exenodj	14	11	risk	risk	NN
cord-285833-7exenodj	14	12	of	of	IN
cord-285833-7exenodj	14	13	admission	admission	NN
cord-285833-7exenodj	14	14	to	to	IN
cord-285833-7exenodj	14	15	the	the	DT
cord-285833-7exenodj	14	16	intensive	intensive	JJ
cord-285833-7exenodj	14	17	care	care	NN
cord-285833-7exenodj	14	18	unit	unit	NN
cord-285833-7exenodj	14	19	,	,	,
cord-285833-7exenodj	14	20	requiring	require	VBG
cord-285833-7exenodj	14	21	invasive	invasive	JJ
cord-285833-7exenodj	14	22	ventilation	ventilation	NN
cord-285833-7exenodj	14	23	,	,	,
cord-285833-7exenodj	14	24	or	or	CC
cord-285833-7exenodj	14	25	death	death	NN
cord-285833-7exenodj	14	26	(	(	-LRB-
cord-285833-7exenodj	14	27	1	1	CD
cord-285833-7exenodj	14	28	)	)	-RRB-
cord-285833-7exenodj	14	29	.	.	.
cord-285833-7exenodj	15	1	Oncologists	oncologist	NNS
cord-285833-7exenodj	15	2	are	be	VBP
cord-285833-7exenodj	15	3	providing	provide	VBG
cord-285833-7exenodj	15	4	optimal	optimal	JJ
cord-285833-7exenodj	15	5	cancer	cancer	NN
cord-285833-7exenodj	15	6	care	care	NN
cord-285833-7exenodj	15	7	and	and	CC
cord-285833-7exenodj	15	8	,	,	,
cord-285833-7exenodj	15	9	simultaneously	simultaneously	RB
cord-285833-7exenodj	15	10	,	,	,
cord-285833-7exenodj	15	11	are	be	VBP
cord-285833-7exenodj	15	12	trying	try	VBG
cord-285833-7exenodj	15	13	to	to	TO
cord-285833-7exenodj	15	14	protect	protect	VB
cord-285833-7exenodj	15	15	these	these	DT
cord-285833-7exenodj	15	16	fragile	fragile	JJ
cord-285833-7exenodj	15	17	patients	patient	NNS
cord-285833-7exenodj	15	18	from	from	IN
cord-285833-7exenodj	15	19	SARS	SARS	NNP
cord-285833-7exenodj	15	20	-	-	HYPH
cord-285833-7exenodj	15	21	CoV-2	CoV-2	NNP
cord-285833-7exenodj	15	22	infection	infection	NN
cord-285833-7exenodj	15	23	and	and	CC
cord-285833-7exenodj	15	24	its	-PRON-	PRP$
cord-285833-7exenodj	15	25	consequences	consequence	NNS
cord-285833-7exenodj	15	26	.	.	.
cord-285833-7exenodj	16	1	Cytopenia	Cytopenia	NNP
cord-285833-7exenodj	16	2	,	,	,
cord-285833-7exenodj	16	3	especially	especially	RB
cord-285833-7exenodj	16	4	neutropenia	neutropenia	NN
cord-285833-7exenodj	16	5	and	and	CC
cord-285833-7exenodj	16	6	lymphopenia	lymphopenia	NNP
cord-285833-7exenodj	16	7	,	,	,
cord-285833-7exenodj	16	8	is	be	VBZ
cord-285833-7exenodj	16	9	the	the	DT
cord-285833-7exenodj	16	10	most	most	RBS
cord-285833-7exenodj	16	11	frustrating	frustrating	JJ
cord-285833-7exenodj	16	12	complication	complication	NN
cord-285833-7exenodj	16	13	of	of	IN
cord-285833-7exenodj	16	14	cancer	cancer	NN
cord-285833-7exenodj	16	15	treatment	treatment	NN
cord-285833-7exenodj	16	16	and	and	CC
cord-285833-7exenodj	16	17	can	can	MD
cord-285833-7exenodj	16	18	increase	increase	VB
cord-285833-7exenodj	16	19	the	the	DT
cord-285833-7exenodj	16	20	susceptibility	susceptibility	NN
cord-285833-7exenodj	16	21	to	to	IN
cord-285833-7exenodj	16	22	infection	infection	NN
cord-285833-7exenodj	16	23	.	.	.
cord-285833-7exenodj	17	1	Both	both	DT
cord-285833-7exenodj	17	2	the	the	DT
cord-285833-7exenodj	17	3	European	European	NNP
cord-285833-7exenodj	17	4	Society	Society	NNP
cord-285833-7exenodj	17	5	for	for	IN
cord-285833-7exenodj	17	6	Medical	Medical	NNP
cord-285833-7exenodj	17	7	Oncology	Oncology	NNP
cord-285833-7exenodj	17	8	(	(	-LRB-
cord-285833-7exenodj	17	9	ESMO	ESMO	NNP
cord-285833-7exenodj	17	10	)	)	-RRB-
cord-285833-7exenodj	17	11	and	and	CC
cord-285833-7exenodj	17	12	the	the	DT
cord-285833-7exenodj	17	13	National	National	NNP
cord-285833-7exenodj	17	14	Comprehensive	Comprehensive	NNP
cord-285833-7exenodj	17	15	Cancer	Cancer	NNP
cord-285833-7exenodj	17	16	Network	Network	NNP
cord-285833-7exenodj	17	17	(	(	-LRB-
cord-285833-7exenodj	17	18	NCCN	NCCN	NNP
cord-285833-7exenodj	17	19	)	)	-RRB-
cord-285833-7exenodj	17	20	have	have	VBP
cord-285833-7exenodj	17	21	recommended	recommend	VBN
cord-285833-7exenodj	17	22	expanding	expand	VBG
cord-285833-7exenodj	17	23	the	the	DT
cord-285833-7exenodj	17	24	indications	indication	NNS
cord-285833-7exenodj	17	25	for	for	IN
cord-285833-7exenodj	17	26	use	use	NN
cord-285833-7exenodj	17	27	of	of	IN
cord-285833-7exenodj	17	28	granulocyte	granulocyte	NN
cord-285833-7exenodj	17	29	colonystimulating	colonystimulating	NN
cord-285833-7exenodj	17	30	factors	factor	NNS
cord-285833-7exenodj	17	31	(	(	-LRB-
cord-285833-7exenodj	17	32	G	g	NN
cord-285833-7exenodj	17	33	-	-	HYPH
cord-285833-7exenodj	17	34	CSFs	csf	NNS
cord-285833-7exenodj	17	35	)	)	-RRB-
cord-285833-7exenodj	17	36	in	in	IN
cord-285833-7exenodj	17	37	cancer	cancer	NN
cord-285833-7exenodj	17	38	patients	patient	NNS
cord-285833-7exenodj	17	39	to	to	TO
cord-285833-7exenodj	17	40	decrease	decrease	VB
cord-285833-7exenodj	17	41	the	the	DT
cord-285833-7exenodj	17	42	risk	risk	NN
cord-285833-7exenodj	17	43	of	of	IN
cord-285833-7exenodj	17	44	neutropenic	neutropenic	JJ
cord-285833-7exenodj	17	45	fever	fever	NN
cord-285833-7exenodj	17	46	and	and	CC
cord-285833-7exenodj	17	47	prevent	prevent	VB
cord-285833-7exenodj	17	48	them	-PRON-	PRP
cord-285833-7exenodj	17	49	from	from	IN
cord-285833-7exenodj	17	50	having	have	VBG
cord-285833-7exenodj	17	51	to	to	TO
cord-285833-7exenodj	17	52	visit	visit	VB
cord-285833-7exenodj	17	53	a	a	DT
cord-285833-7exenodj	17	54	hospital	hospital	NN
cord-285833-7exenodj	17	55	(	(	-LRB-
cord-285833-7exenodj	17	56	2	2	CD
cord-285833-7exenodj	17	57	,	,	,
cord-285833-7exenodj	17	58	3	3	CD
cord-285833-7exenodj	17	59	)	)	-RRB-
cord-285833-7exenodj	17	60	.	.	.
cord-285833-7exenodj	18	1	The	the	DT
cord-285833-7exenodj	18	2	efficacy	efficacy	NN
cord-285833-7exenodj	18	3	of	of	IN
cord-285833-7exenodj	18	4	G	g	NN
cord-285833-7exenodj	18	5	-	-	HYPH
cord-285833-7exenodj	18	6	CSFs	csf	NNS
cord-285833-7exenodj	18	7	in	in	IN
cord-285833-7exenodj	18	8	preventing	prevent	VBG
cord-285833-7exenodj	18	9	febrile	febrile	JJ
cord-285833-7exenodj	18	10	neutropenia	neutropenia	NN
cord-285833-7exenodj	18	11	and	and	CC
cord-285833-7exenodj	18	12	treatment	treatment	NN
cord-285833-7exenodj	18	13	-	-	HYPH
cord-285833-7exenodj	18	14	related	relate	VBN
cord-285833-7exenodj	18	15	hospitalizations	hospitalization	NNS
cord-285833-7exenodj	18	16	has	have	VBZ
cord-285833-7exenodj	18	17	been	be	VBN
cord-285833-7exenodj	18	18	well	well	RB
cord-285833-7exenodj	18	19	documented	document	VBN
cord-285833-7exenodj	18	20	in	in	IN
cord-285833-7exenodj	18	21	earlier	early	JJR
cord-285833-7exenodj	18	22	studies	study	NNS
cord-285833-7exenodj	18	23	.	.	.
cord-285833-7exenodj	19	1	Moreover	moreover	RB
cord-285833-7exenodj	19	2	,	,	,
cord-285833-7exenodj	19	3	a	a	DT
cord-285833-7exenodj	19	4	5-day	5-day	JJ
cord-285833-7exenodj	19	5	course	course	NN
cord-285833-7exenodj	19	6	of	of	IN
cord-285833-7exenodj	19	7	G	G	NNP
cord-285833-7exenodj	19	8	-	-	HYPH
cord-285833-7exenodj	19	9	CSF	csf	NN
cord-285833-7exenodj	19	10	prophylaxis	prophylaxis	NN
cord-285833-7exenodj	19	11	in	in	IN
cord-285833-7exenodj	19	12	most	most	JJS
cord-285833-7exenodj	19	13	chemotherapy	chemotherapy	NN
cord-285833-7exenodj	19	14	regimens	regimen	NNS
cord-285833-7exenodj	19	15	has	have	VBZ
cord-285833-7exenodj	19	16	been	be	VBN
cord-285833-7exenodj	19	17	reported	report	VBN
cord-285833-7exenodj	19	18	to	to	TO
cord-285833-7exenodj	19	19	be	be	VB
cord-285833-7exenodj	19	20	effective	effective	JJ
cord-285833-7exenodj	19	21	(	(	-LRB-
cord-285833-7exenodj	19	22	4	4	CD
cord-285833-7exenodj	19	23	)	)	-RRB-
cord-285833-7exenodj	19	24	;	;	:
cord-285833-7exenodj	19	25	however	however	RB
cord-285833-7exenodj	19	26	,	,	,
cord-285833-7exenodj	19	27	limited	limited	JJ
cord-285833-7exenodj	19	28	data	datum	NNS
cord-285833-7exenodj	19	29	are	be	VBP
cord-285833-7exenodj	19	30	available	available	JJ
cord-285833-7exenodj	19	31	on	on	IN
cord-285833-7exenodj	19	32	its	-PRON-	PRP$
cord-285833-7exenodj	19	33	efficacy	efficacy	NN
cord-285833-7exenodj	19	34	in	in	IN
cord-285833-7exenodj	19	35	COVID-19	COVID-19	NNP
cord-285833-7exenodj	19	36	patients	patient	NNS
cord-285833-7exenodj	19	37	.	.	.
cord-285833-7exenodj	20	1	G	g	NN
cord-285833-7exenodj	20	2	-	-	HYPH
cord-285833-7exenodj	20	3	CSFs	csf	NNS
cord-285833-7exenodj	20	4	are	be	VBP
cord-285833-7exenodj	20	5	growth	growth	NN
cord-285833-7exenodj	20	6	factors	factor	NNS
cord-285833-7exenodj	20	7	that	that	WDT
cord-285833-7exenodj	20	8	stimulate	stimulate	VBP
cord-285833-7exenodj	20	9	the	the	DT
cord-285833-7exenodj	20	10	survival	survival	NN
cord-285833-7exenodj	20	11	,	,	,
cord-285833-7exenodj	20	12	proliferation	proliferation	NN
cord-285833-7exenodj	20	13	,	,	,
cord-285833-7exenodj	20	14	differentiation	differentiation	NN
cord-285833-7exenodj	20	15	,	,	,
cord-285833-7exenodj	20	16	and	and	CC
cord-285833-7exenodj	20	17	function	function	NN
cord-285833-7exenodj	20	18	of	of	IN
cord-285833-7exenodj	20	19	neutrophil	neutrophil	NN
cord-285833-7exenodj	20	20	precursors	precursor	NNS
cord-285833-7exenodj	20	21	and	and	CC
cord-285833-7exenodj	20	22	mature	mature	VB
cord-285833-7exenodj	20	23	neutrophils	neutrophil	NNS
cord-285833-7exenodj	20	24	via	via	IN
cord-285833-7exenodj	20	25	signal	signal	NN
cord-285833-7exenodj	20	26	transduction	transduction	NN
cord-285833-7exenodj	20	27	pathways	pathway	NNS
cord-285833-7exenodj	20	28	.	.	.
cord-285833-7exenodj	21	1	Studies	study	NNS
cord-285833-7exenodj	21	2	on	on	IN
cord-285833-7exenodj	21	3	healthy	healthy	JJ
cord-285833-7exenodj	21	4	volunteers	volunteer	NNS
cord-285833-7exenodj	21	5	revealed	reveal	VBD
cord-285833-7exenodj	21	6	that	that	IN
cord-285833-7exenodj	21	7	the	the	DT
cord-285833-7exenodj	21	8	administration	administration	NN
cord-285833-7exenodj	21	9	of	of	IN
cord-285833-7exenodj	21	10	G	G	NNP
cord-285833-7exenodj	21	11	-	-	HYPH
cord-285833-7exenodj	21	12	CSFs	CSFs	NNP
cord-285833-7exenodj	21	13	resulted	result	VBD
cord-285833-7exenodj	21	14	in	in	IN
cord-285833-7exenodj	21	15	increased	increase	VBD
cord-285833-7exenodj	21	16	the	the	DT
cord-285833-7exenodj	21	17	levels	level	NNS
cord-285833-7exenodj	21	18	of	of	IN
cord-285833-7exenodj	21	19	interleukin	interleukin	NN
cord-285833-7exenodj	21	20	(	(	-LRB-
cord-285833-7exenodj	21	21	IL)-1	IL)-1	''
cord-285833-7exenodj	21	22	,	,	,
cord-285833-7exenodj	21	23	soluble	soluble	JJ
cord-285833-7exenodj	21	24	tumor	tumor	NN
cord-285833-7exenodj	21	25	necrosis	necrosis	NN
cord-285833-7exenodj	21	26	factor	factor	NN
cord-285833-7exenodj	21	27	(	(	-LRB-
cord-285833-7exenodj	21	28	TNF	TNF	NNP
cord-285833-7exenodj	21	29	)	)	-RRB-
cord-285833-7exenodj	21	30	receptors	receptor	NNS
cord-285833-7exenodj	21	31	(	(	-LRB-
cord-285833-7exenodj	21	32	sTNF	stnf	NN
cord-285833-7exenodj	21	33	-	-	HYPH
cord-285833-7exenodj	21	34	Rs	r	NNS
cord-285833-7exenodj	21	35	)	)	-RRB-
cord-285833-7exenodj	21	36	,	,	,
cord-285833-7exenodj	21	37	IL-6	IL-6	NNP
cord-285833-7exenodj	21	38	,	,	,
cord-285833-7exenodj	21	39	IL-8	IL-8	NNP
cord-285833-7exenodj	21	40	,	,	,
cord-285833-7exenodj	21	41	and	and	CC
cord-285833-7exenodj	21	42	IL-10	IL-10	NNP
cord-285833-7exenodj	21	43	and	and	CC
cord-285833-7exenodj	21	44	reduced	reduce	VBD
cord-285833-7exenodj	21	45	the	the	DT
cord-285833-7exenodj	21	46	levels	level	NNS
cord-285833-7exenodj	21	47	of	of	IN
cord-285833-7exenodj	21	48	TNF	TNF	NNP
cord-285833-7exenodj	21	49	-	-	HYPH
cord-285833-7exenodj	21	50	a	a	NNP
cord-285833-7exenodj	21	51	,	,	,
cord-285833-7exenodj	21	52	interferon	interferon	NN
cord-285833-7exenodj	21	53	(	(	-LRB-
cord-285833-7exenodj	21	54	IFN)-g	IFN)-g	NNP
cord-285833-7exenodj	21	55	,	,	,
cord-285833-7exenodj	21	56	and	and	CC
cord-285833-7exenodj	21	57	granulocyte	granulocyte	NN
cord-285833-7exenodj	21	58	-	-	HYPH
cord-285833-7exenodj	21	59	macrophage	macrophage	NN
cord-285833-7exenodj	21	60	colony	colony	NN
cord-285833-7exenodj	21	61	-	-	HYPH
cord-285833-7exenodj	21	62	stimulating	stimulate	VBG
cord-285833-7exenodj	21	63	factor	factor	NN
cord-285833-7exenodj	21	64	(	(	-LRB-
cord-285833-7exenodj	21	65	GM	GM	NNP
cord-285833-7exenodj	21	66	-	-	HYPH
cord-285833-7exenodj	21	67	CSF	CSF	NNP
cord-285833-7exenodj	21	68	)	)	-RRB-
cord-285833-7exenodj	21	69	(	(	-LRB-
cord-285833-7exenodj	21	70	5	5	CD
cord-285833-7exenodj	21	71	)	)	-RRB-
cord-285833-7exenodj	21	72	.	.	.
cord-285833-7exenodj	22	1	Data	datum	NNS
cord-285833-7exenodj	22	2	from	from	IN
cord-285833-7exenodj	22	3	a	a	DT
cord-285833-7exenodj	22	4	limited	limited	JJ
cord-285833-7exenodj	22	5	number	number	NN
cord-285833-7exenodj	22	6	of	of	IN
cord-285833-7exenodj	22	7	COVID-19	covid-19	JJ
cord-285833-7exenodj	22	8	patients	patient	NNS
cord-285833-7exenodj	22	9	have	have	VBP
cord-285833-7exenodj	22	10	shown	show	VBN
cord-285833-7exenodj	22	11	a	a	DT
cord-285833-7exenodj	22	12	cytokine	cytokine	NN
cord-285833-7exenodj	22	13	storm	storm	NN
cord-285833-7exenodj	22	14	in	in	IN
cord-285833-7exenodj	22	15	critically	critically	RB
cord-285833-7exenodj	22	16	ill	ill	JJ
cord-285833-7exenodj	22	17	patients	patient	NNS
cord-285833-7exenodj	22	18	.	.	.
cord-285833-7exenodj	23	1	Besides	besides	RB
cord-285833-7exenodj	23	2	,	,	,
cord-285833-7exenodj	23	3	the	the	DT
cord-285833-7exenodj	23	4	levels	level	NNS
cord-285833-7exenodj	23	5	of	of	IN
cord-285833-7exenodj	23	6	IL-2	IL-2	NNP
cord-285833-7exenodj	23	7	,	,	,
cord-285833-7exenodj	23	8	IL-6	IL-6	NNP
cord-285833-7exenodj	23	9	,	,	,
cord-285833-7exenodj	23	10	IL-10	IL-10	NNP
cord-285833-7exenodj	23	11	,	,	,
cord-285833-7exenodj	23	12	and	and	CC
cord-285833-7exenodj	23	13	IFN	IFN	NNP
cord-285833-7exenodj	23	14	-	-	HYPH
cord-285833-7exenodj	23	15	g	g	NNP
cord-285833-7exenodj	23	16	were	be	VBD
cord-285833-7exenodj	23	17	found	find	VBN
cord-285833-7exenodj	23	18	to	to	TO
cord-285833-7exenodj	23	19	be	be	VB
cord-285833-7exenodj	23	20	higher	high	JJR
cord-285833-7exenodj	23	21	in	in	IN
cord-285833-7exenodj	23	22	severe	severe	JJ
cord-285833-7exenodj	23	23	cases	case	NNS
cord-285833-7exenodj	23	24	of	of	IN
cord-285833-7exenodj	23	25	COVID-19	covid-19	CD
cord-285833-7exenodj	23	26	than	than	IN
cord-285833-7exenodj	23	27	in	in	IN
cord-285833-7exenodj	23	28	mild	mild	JJ
cord-285833-7exenodj	23	29	cases	case	NNS
cord-285833-7exenodj	23	30	,	,	,
cord-285833-7exenodj	23	31	and	and	CC
cord-285833-7exenodj	23	32	a	a	DT
cord-285833-7exenodj	23	33	strong	strong	JJ
cord-285833-7exenodj	23	34	inflammatory	inflammatory	JJ
cord-285833-7exenodj	23	35	response	response	NN
cord-285833-7exenodj	23	36	during	during	IN
cord-285833-7exenodj	23	37	its	-PRON-	PRP$
cord-285833-7exenodj	23	38	clinical	clinical	JJ
cord-285833-7exenodj	23	39	course	course	NN
cord-285833-7exenodj	23	40	was	be	VBD
cord-285833-7exenodj	23	41	reported	report	VBN
cord-285833-7exenodj	23	42	to	to	TO
cord-285833-7exenodj	23	43	be	be	VB
cord-285833-7exenodj	23	44	associated	associate	VBN
cord-285833-7exenodj	23	45	with	with	IN
cord-285833-7exenodj	23	46	high	high	JJ
cord-285833-7exenodj	23	47	morbidity	morbidity	NN
cord-285833-7exenodj	23	48	and	and	CC
cord-285833-7exenodj	23	49	mortality	mortality	NN
cord-285833-7exenodj	23	50	(	(	-LRB-
cord-285833-7exenodj	23	51	6	6	CD
cord-285833-7exenodj	23	52	)	)	-RRB-
cord-285833-7exenodj	23	53	.	.	.
cord-285833-7exenodj	24	1	Clinical	clinical	JJ
cord-285833-7exenodj	24	2	outcomes	outcome	NNS
cord-285833-7exenodj	24	3	are	be	VBP
cord-285833-7exenodj	24	4	also	also	RB
cord-285833-7exenodj	24	5	unpredictable	unpredictable	JJ
cord-285833-7exenodj	24	6	in	in	IN
cord-285833-7exenodj	24	7	COVID-19	covid-19	JJ
cord-285833-7exenodj	24	8	patients	patient	NNS
cord-285833-7exenodj	24	9	with	with	IN
cord-285833-7exenodj	24	10	high	high	JJ
cord-285833-7exenodj	24	11	levels	level	NNS
cord-285833-7exenodj	24	12	of	of	IN
cord-285833-7exenodj	24	13	inflammatory	inflammatory	JJ
cord-285833-7exenodj	24	14	cytokines	cytokine	NNS
cord-285833-7exenodj	24	15	undergoing	undergo	VBG
cord-285833-7exenodj	24	16	G	G	NNP
cord-285833-7exenodj	24	17	-	-	HYPH
cord-285833-7exenodj	24	18	CSF	csf	NN
cord-285833-7exenodj	24	19	prophylaxis	prophylaxis	NN
cord-285833-7exenodj	24	20	.	.	.
cord-285833-7exenodj	25	1	Furthermore	furthermore	RB
cord-285833-7exenodj	25	2	,	,	,
cord-285833-7exenodj	25	3	there	there	EX
cord-285833-7exenodj	25	4	are	be	VBP
cord-285833-7exenodj	25	5	chances	chance	NNS
cord-285833-7exenodj	25	6	of	of	IN
cord-285833-7exenodj	25	7	acute	acute	JJ
cord-285833-7exenodj	25	8	respiratory	respiratory	JJ
cord-285833-7exenodj	25	9	failure	failure	NN
cord-285833-7exenodj	25	10	during	during	IN
cord-285833-7exenodj	25	11	G	G	NNP
cord-285833-7exenodj	25	12	-	-	HYPH
cord-285833-7exenodj	25	13	CSF	csf	NN
cord-285833-7exenodj	25	14	-	-	HYPH
cord-285833-7exenodj	25	15	induced	induce	VBN
cord-285833-7exenodj	25	16	neutropenia	neutropenia	NN
cord-285833-7exenodj	25	17	recovery	recovery	NN
cord-285833-7exenodj	25	18	.	.	.
cord-285833-7exenodj	26	1	G	g	NN
cord-285833-7exenodj	26	2	-	-	HYPH
cord-285833-7exenodj	26	3	CSFs	csf	NNS
cord-285833-7exenodj	26	4	have	have	VBP
cord-285833-7exenodj	26	5	been	be	VBN
cord-285833-7exenodj	26	6	reported	report	VBN
cord-285833-7exenodj	26	7	to	to	TO
cord-285833-7exenodj	26	8	be	be	VB
cord-285833-7exenodj	26	9	associated	associate	VBN
cord-285833-7exenodj	26	10	with	with	IN
cord-285833-7exenodj	26	11	activation	activation	NN
cord-285833-7exenodj	26	12	of	of	IN
cord-285833-7exenodj	26	13	the	the	DT
cord-285833-7exenodj	26	14	oxidative	oxidative	JJ
cord-285833-7exenodj	26	15	burst	burst	NN
cord-285833-7exenodj	26	16	mechanism	mechanism	NN
cord-285833-7exenodj	26	17	within	within	IN
cord-285833-7exenodj	26	18	circulating	circulate	VBG
cord-285833-7exenodj	26	19	or	or	CC
cord-285833-7exenodj	26	20	resident	resident	JJ
cord-285833-7exenodj	26	21	alveolar	alveolar	JJ
cord-285833-7exenodj	26	22	neutrophils	neutrophil	NNS
cord-285833-7exenodj	26	23	and	and	CC
cord-285833-7exenodj	26	24	macrophages	macrophage	NNS
cord-285833-7exenodj	26	25	,	,	,
cord-285833-7exenodj	26	26	further	further	RB
cord-285833-7exenodj	26	27	complicating	complicate	VBG
cord-285833-7exenodj	26	28	the	the	DT
cord-285833-7exenodj	26	29	situation	situation	NN
cord-285833-7exenodj	26	30	(	(	-LRB-
cord-285833-7exenodj	26	31	7	7	CD
cord-285833-7exenodj	26	32	,	,	,
cord-285833-7exenodj	26	33	8)	8)	NN
cord-285833-7exenodj	26	34	.	.	.
cord-285833-7exenodj	27	1	Therefore	therefore	RB
cord-285833-7exenodj	27	2	,	,	,
cord-285833-7exenodj	27	3	devastating	devastating	JJ
cord-285833-7exenodj	27	4	results	result	NNS
cord-285833-7exenodj	27	5	can	can	MD
cord-285833-7exenodj	27	6	potentially	potentially	RB
cord-285833-7exenodj	27	7	be	be	VB
cord-285833-7exenodj	27	8	seen	see	VBN
cord-285833-7exenodj	27	9	in	in	IN
cord-285833-7exenodj	28	1	COVID-19-positive	covid-19-positive	JJ
cord-285833-7exenodj	28	2	patients	patient	NNS
cord-285833-7exenodj	28	3	administered	administer	VBD
cord-285833-7exenodj	28	4	G	G	NNP
cord-285833-7exenodj	28	5	-	-	HYPH
cord-285833-7exenodj	28	6	CFSs	cfs	NNS
cord-285833-7exenodj	28	7	or	or	CC
cord-285833-7exenodj	28	8	in	in	IN
cord-285833-7exenodj	28	9	those	those	DT
cord-285833-7exenodj	28	10	exposed	expose	VBN
cord-285833-7exenodj	28	11	to	to	IN
cord-285833-7exenodj	28	12	infection	infection	NN
cord-285833-7exenodj	28	13	while	while	IN
cord-285833-7exenodj	28	14	undergoing	undergo	VBG
cord-285833-7exenodj	28	15	G	G	NNP
cord-285833-7exenodj	28	16	-	-	HYPH
cord-285833-7exenodj	28	17	CSF	csf	NN
cord-285833-7exenodj	28	18	therapy	therapy	NN
cord-285833-7exenodj	28	19	.	.	.
cord-285833-7exenodj	29	1	However	however	RB
cord-285833-7exenodj	29	2	,	,	,
cord-285833-7exenodj	29	3	very	very	RB
cord-285833-7exenodj	29	4	limited	limited	JJ
cord-285833-7exenodj	29	5	data	datum	NNS
cord-285833-7exenodj	29	6	on	on	IN
cord-285833-7exenodj	29	7	the	the	DT
cord-285833-7exenodj	29	8	outcomes	outcome	NNS
cord-285833-7exenodj	29	9	of	of	IN
cord-285833-7exenodj	29	10	chemotherapy	chemotherapy	NN
cord-285833-7exenodj	29	11	in	in	IN
cord-285833-7exenodj	29	12	cancer	cancer	NN
cord-285833-7exenodj	29	13	patients	patient	NNS
cord-285833-7exenodj	29	14	in	in	IN
cord-285833-7exenodj	29	15	the	the	DT
cord-285833-7exenodj	29	16	COVID-19	COVID-19	NNP
cord-285833-7exenodj	29	17	era	era	NN
cord-285833-7exenodj	29	18	are	be	VBP
cord-285833-7exenodj	29	19	currently	currently	RB
cord-285833-7exenodj	29	20	available	available	JJ
cord-285833-7exenodj	29	21	,	,	,
cord-285833-7exenodj	29	22	with	with	IN
cord-285833-7exenodj	29	23	no	no	DT
cord-285833-7exenodj	29	24	specific	specific	JJ
cord-285833-7exenodj	29	25	subgroup	subgroup	NN
cord-285833-7exenodj	29	26	analysis	analysis	NN
cord-285833-7exenodj	29	27	in	in	IN
cord-285833-7exenodj	29	28	patients	patient	NNS
cord-285833-7exenodj	29	29	treated	treat	VBN
cord-285833-7exenodj	29	30	with	with	IN
cord-285833-7exenodj	29	31	G	g	NN
cord-285833-7exenodj	29	32	-	-	HYPH
cord-285833-7exenodj	29	33	CSFs	csf	NNS
cord-285833-7exenodj	29	34	.	.	.
cord-285833-7exenodj	30	1	Although	although	IN
cord-285833-7exenodj	30	2	the	the	DT
cord-285833-7exenodj	30	3	described	describe	VBN
cord-285833-7exenodj	30	4	scenarios	scenario	NNS
cord-285833-7exenodj	30	5	are	be	VBP
cord-285833-7exenodj	30	6	theoretical	theoretical	JJ
cord-285833-7exenodj	30	7	and	and	CC
cord-285833-7exenodj	30	8	speculative	speculative	JJ
cord-285833-7exenodj	30	9	,	,	,
cord-285833-7exenodj	30	10	both	both	CC
cord-285833-7exenodj	30	11	NCCN	NCCN	NNP
cord-285833-7exenodj	30	12	and	and	CC
cord-285833-7exenodj	30	13	ESMO	ESMO	NNP
cord-285833-7exenodj	30	14	have	have	VBP
cord-285833-7exenodj	30	15	concluded	conclude	VBN
cord-285833-7exenodj	30	16	that	that	IN
cord-285833-7exenodj	30	17	the	the	DT
cord-285833-7exenodj	30	18	benefits	benefit	NNS
cord-285833-7exenodj	30	19	of	of	IN
cord-285833-7exenodj	30	20	G	G	NNP
cord-285833-7exenodj	30	21	-	-	HYPH
cord-285833-7exenodj	30	22	CSF	CSF	NNP
cord-285833-7exenodj	30	23	administration	administration	NN
cord-285833-7exenodj	30	24	outweigh	outweigh	VBP
cord-285833-7exenodj	30	25	its	-PRON-	PRP$
cord-285833-7exenodj	30	26	risks	risk	NNS
cord-285833-7exenodj	30	27	and	and	CC
cord-285833-7exenodj	30	28	have	have	VBP
cord-285833-7exenodj	30	29	,	,	,
cord-285833-7exenodj	30	30	therefore	therefore	RB
cord-285833-7exenodj	30	31	,	,	,
cord-285833-7exenodj	30	32	recommended	recommend	VBD
cord-285833-7exenodj	30	33	its	-PRON-	PRP$
cord-285833-7exenodj	30	34	use	use	NN
cord-285833-7exenodj	30	35	with	with	IN
cord-285833-7exenodj	30	36	caution	caution	NN
cord-285833-7exenodj	30	37	.	.	.
cord-285833-7exenodj	31	1	Until	until	IN
cord-285833-7exenodj	31	2	more	more	JJR
cord-285833-7exenodj	31	3	data	datum	NNS
cord-285833-7exenodj	31	4	are	be	VBP
cord-285833-7exenodj	31	5	available	available	JJ
cord-285833-7exenodj	31	6	,	,	,
cord-285833-7exenodj	31	7	clinicians	clinician	NNS
cord-285833-7exenodj	31	8	should	should	MD
cord-285833-7exenodj	31	9	be	be	VB
cord-285833-7exenodj	31	10	more	more	RBR
cord-285833-7exenodj	31	11	cautious	cautious	JJ
cord-285833-7exenodj	31	12	with	with	IN
cord-285833-7exenodj	31	13	the	the	DT
cord-285833-7exenodj	31	14	use	use	NN
cord-285833-7exenodj	31	15	of	of	IN
cord-285833-7exenodj	31	16	G	g	NN
cord-285833-7exenodj	31	17	-	-	HYPH
cord-285833-7exenodj	31	18	CSFs	csf	NNS
cord-285833-7exenodj	31	19	in	in	IN
cord-285833-7exenodj	31	20	cancer	cancer	NN
cord-285833-7exenodj	31	21	patients	patient	NNS
cord-285833-7exenodj	31	22	in	in	IN
cord-285833-7exenodj	31	23	the	the	DT
cord-285833-7exenodj	31	24	COVID-19	COVID-19	NNP
cord-285833-7exenodj	31	25	era	era	NN
cord-285833-7exenodj	31	26	.	.	.
cord-285833-7exenodj	31	27	'	'	''
cord-285833-7exenodj	32	1	REFERENCES	reference	VBG
cord-285833-7exenodj	32	2	Cancer	cancer	NN
cord-285833-7exenodj	32	3	patients	patient	NNS
cord-285833-7exenodj	32	4	in	in	IN
cord-285833-7exenodj	32	5	SARS	SARS	NNP
cord-285833-7exenodj	32	6	-	-	HYPH
cord-285833-7exenodj	32	7	CoV-2	CoV-2	NNP
cord-285833-7exenodj	32	8	infection	infection	NN
cord-285833-7exenodj	32	9	:	:	:
cord-285833-7exenodj	32	10	a	a	DT
cord-285833-7exenodj	32	11	nationwide	nationwide	JJ
cord-285833-7exenodj	32	12	analysis	analysis	NN
cord-285833-7exenodj	32	13	in	in	IN
cord-285833-7exenodj	32	14	China	China	NNP
cord-285833-7exenodj	32	15	SUPPORTIVE	supportive	JJ
cord-285833-7exenodj	32	16	CARE	care	NN
cord-285833-7exenodj	32	17	STRATEGIES	strategy	NNS
cord-285833-7exenodj	32	18	DURING	during	IN
cord-285833-7exenodj	32	19	THE	the	DT
cord-285833-7exenodj	32	20	COVID-19	COVID-19	NNP
cord-285833-7exenodj	32	21	PANDEMIC	PANDEMIC	NNP
cord-285833-7exenodj	32	22	Hematopoietic	Hematopoietic	NNP
cord-285833-7exenodj	32	23	Growth	Growth	NNP
cord-285833-7exenodj	32	24	Factors	Factors	NNPS
cord-285833-7exenodj	32	25	.	.	.
cord-285833-7exenodj	33	1	Short	Short	NNP
cord-285833-7exenodj	33	2	-	-	HYPH
cord-285833-7exenodj	33	3	Term	Term	NNP
cord-285833-7exenodj	33	4	Recommendations	Recommendations	NNPS
cord-285833-7exenodj	34	1	Specific	specific	JJ
cord-285833-7exenodj	34	2	to	to	IN
cord-285833-7exenodj	34	3	Issues	issue	NNS
cord-285833-7exenodj	34	4	with	with	IN
cord-285833-7exenodj	34	5	COVID-19	COVID-19	NNP
cord-285833-7exenodj	35	1	(	(	-LRB-
cord-285833-7exenodj	35	2	SARS	SARS	NNP
cord-285833-7exenodj	35	3	-	-	HYPH
cord-285833-7exenodj	35	4	CoV-2	CoV-2	NNP
cord-285833-7exenodj	35	5	)	)	-RRB-
cord-285833-7exenodj	36	1	A	a	DT
cord-285833-7exenodj	36	2	multicentre	multicentre	NNP
cord-285833-7exenodj	36	3	,	,	,
cord-285833-7exenodj	36	4	randomised	randomised	JJ
cord-285833-7exenodj	36	5	trial	trial	NN
cord-285833-7exenodj	36	6	comparing	compare	VBG
cord-285833-7exenodj	36	7	schedules	schedule	NNS
cord-285833-7exenodj	36	8	of	of	IN
cord-285833-7exenodj	36	9	G	G	NNP
cord-285833-7exenodj	36	10	-	-	HYPH
cord-285833-7exenodj	36	11	CSF	CSF	NNP
cord-285833-7exenodj	36	12	(	(	-LRB-
cord-285833-7exenodj	36	13	filgrastim	filgrastim	NNP
cord-285833-7exenodj	36	14	)	)	-RRB-
cord-285833-7exenodj	36	15	administration	administration	NN
cord-285833-7exenodj	36	16	for	for	IN
cord-285833-7exenodj	36	17	primary	primary	JJ
cord-285833-7exenodj	36	18	prophylaxis	prophylaxis	NN
cord-285833-7exenodj	36	19	of	of	IN
cord-285833-7exenodj	36	20	chemotherapy	chemotherapy	NN
cord-285833-7exenodj	36	21	-	-	HYPH
cord-285833-7exenodj	36	22	induced	induce	VBN
cord-285833-7exenodj	36	23	febrile	febrile	JJ
cord-285833-7exenodj	36	24	neutropenia	neutropenia	NN
cord-285833-7exenodj	36	25	in	in	IN
cord-285833-7exenodj	36	26	early	early	JJ
cord-285833-7exenodj	36	27	stage	stage	NN
cord-285833-7exenodj	36	28	breast	breast	NN
cord-285833-7exenodj	36	29	cancer	cancer	NN
cord-285833-7exenodj	36	30	Effect	effect	NN
cord-285833-7exenodj	36	31	of	of	IN
cord-285833-7exenodj	36	32	granulocyte	granulocyte	NN
cord-285833-7exenodj	36	33	colony	colony	NN
cord-285833-7exenodj	36	34	-	-	HYPH
cord-285833-7exenodj	36	35	stimulating	stimulate	VBG
cord-285833-7exenodj	36	36	factor	factor	NN
cord-285833-7exenodj	36	37	treatment	treatment	NN
cord-285833-7exenodj	36	38	on	on	IN
cord-285833-7exenodj	36	39	ex	ex	FW
cord-285833-7exenodj	36	40	vivo	vivo	NN
cord-285833-7exenodj	36	41	blood	blood	NN
cord-285833-7exenodj	36	42	cytokine	cytokine	NN
cord-285833-7exenodj	36	43	response	response	NN
cord-285833-7exenodj	36	44	in	in	IN
cord-285833-7exenodj	36	45	human	human	JJ
cord-285833-7exenodj	36	46	volunteers	volunteer	NNS
cord-285833-7exenodj	36	47	Longitudinal	longitudinal	JJ
cord-285833-7exenodj	36	48	characteristics	characteristic	NNS
cord-285833-7exenodj	36	49	of	of	IN
cord-285833-7exenodj	36	50	lymphocyte	lymphocyte	NN
cord-285833-7exenodj	36	51	responses	response	NNS
cord-285833-7exenodj	36	52	and	and	CC
cord-285833-7exenodj	36	53	cytokine	cytokine	NN
cord-285833-7exenodj	36	54	profiles	profile	NNS
cord-285833-7exenodj	36	55	in	in	IN
cord-285833-7exenodj	36	56	the	the	DT
cord-285833-7exenodj	36	57	peripheral	peripheral	JJ
cord-285833-7exenodj	36	58	blood	blood	NN
cord-285833-7exenodj	36	59	of	of	IN
cord-285833-7exenodj	36	60	SARS	SARS	NNP
cord-285833-7exenodj	36	61	-	-	HYPH
cord-285833-7exenodj	36	62	CoV-2	CoV-2	NNP
cord-285833-7exenodj	36	63	infected	infect	VBN
cord-285833-7exenodj	36	64	patients	patient	NNS
cord-285833-7exenodj	36	65	.	.	.
cord-285833-7exenodj	37	1	Version	version	NN
cord-285833-7exenodj	37	2	2	2	CD
cord-285833-7exenodj	37	3	Deterioration	deterioration	NN
cord-285833-7exenodj	37	4	of	of	IN
cord-285833-7exenodj	37	5	previous	previous	JJ
cord-285833-7exenodj	37	6	acute	acute	JJ
cord-285833-7exenodj	37	7	lung	lung	NN
cord-285833-7exenodj	37	8	injury	injury	NN
cord-285833-7exenodj	37	9	during	during	IN
cord-285833-7exenodj	37	10	neutropenia	neutropenia	NN
cord-285833-7exenodj	37	11	recovery	recovery	NN
cord-285833-7exenodj	37	12	Respiratory	respiratory	JJ
cord-285833-7exenodj	37	13	status	status	NN
cord-285833-7exenodj	37	14	deterioration	deterioration	NN
cord-285833-7exenodj	37	15	during	during	IN
cord-285833-7exenodj	37	16	G	G	NNP
cord-285833-7exenodj	37	17	-	-	HYPH
cord-285833-7exenodj	37	18	CSF	csf	NN
cord-285833-7exenodj	37	19	-	-	HYPH
cord-285833-7exenodj	37	20	induced	induce	VBN
cord-285833-7exenodj	37	21	neutropenia	neutropenia	NN
cord-285833-7exenodj	37	22	recovery	recovery	NN